Haloperidol Decanoate is the decanoate ester of haloperidol, a phenylbutylpiperadine derivative with antipsychotic, neuroleptic and antiemetic effects. Haloperidol competitively blocks postsynaptic dopamine (D2) receptors in the mesolimbic system of the brain leading to anti-delusionary and anti-hallucinogenic effects. The antagonistic activity mediated through D2 dopamine receptors in the chemoreceptive trigger zone (CTZ) account for its antiemetic activity. It is grouped under the following drug class(es): Neurotransmitter agents. Its therapeutic use is listed as central nervous system (CNS) agents and veterinary tranquilizers. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Haldol Dec and Halomonth. Its PubChem CID is 52919.
Haloperidol decanoate
| CAS No | 74050-97-8 |
|---|---|
| Molecular Formula | C31H41ClFNO3 |
| Molecular Weight | 530.1 g/mol |
| Synonyms | [4-(4-Chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl] decanoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Haloperidol Decanoate is the decanoate ester of haloperidol, a phenylbutylpiperadine derivative with antipsychotic, neuroleptic and antiemetic effects.
The listed CAS number is 74050-97-8.
The listed molecular formula is C31H41ClFNO3.
The listed molecular weight is 530.1 g/mol.
[4-(4-Chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl] decanoate.
The source lists Haldol Dec and Halomonth.